Free Trial

Revance Therapeutics (RVNC) Institutional Ownership

→ Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad)
Free RVNC Stock Alerts
$3.40
+0.11 (+3.34%)
(As of 04/26/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Institutional Ownership Changes (13F Filings) for Revance Therapeutics (NASDAQ:RVNC)

Current
Institutional Ownership
Percentage
97.70%
Number of
Institutional Buyers
(last 12 months)
95
Total
Institutional Inflows
(last 12 months)
$231.16M
Number of
Institutional Sellers
(last 12 months)
45
Total
Institutional Outflows
(last 12 months)
$286.38M
Get RVNC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Revance Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

RVNC Institutional Buying and Selling by Quarter

Revance Therapeutics Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
4/23/2024 Rice Hall James & Associates LLC746,139$3.67M0.2%-1.6%0.716%
4/5/2024 Los Angeles Capital Management LLC92,918$457K0.0%N/A0.089%
3/26/2024HighPoint Advisor Group LLC11,157$98K0.0%N/A0.011%
3/5/2024Wellington Management Group LLP449,685$3.95M0.0%-58.5%0.510%
2/26/2024Centaurus Financial Inc.17,612$155K0.0%-28.2%0.020%
2/26/2024Virtu Financial LLC24,946$219K0.0%-31.4%0.028%
2/22/2024Sierra Summit Advisors LLC86,421$760K0.2%N/A0.098%
2/14/2024Nebula Research & Development LLC105,295$926K0.3%N/A0.120%
2/14/2024Rubric Capital Management LP1,461,474$12.85M0.3%-8.7%1.664%
2/13/2024Tower Research Capital LLC TRC 6,823$60K0.0%+626.6%0.008%
2/13/2024Capital World Investors11,939,076$104.94M0.0%-0.2%13.596%
2/13/2024DCF Advisers LLC256,872$2.26M1.2%+869.3%0.293%
2/13/2024Rhenman & Partners Asset Management AB475,872$4.18M0.4%+31.6%0.542%
2/13/2024CIBC Asset Management Inc1,147,294$10.09M0.0%+251.2%1.307%
2/12/2024Capstone Investment Advisors LLC19,449$171K0.0%N/A0.022%
2/9/2024Aigen Investment Management LP19,569$172K0.0%N/A0.022%
2/9/2024Quest Partners LLC9,532$84K0.0%N/A0.011%
2/9/2024Trexquant Investment LP65,759$578K0.0%N/A0.075%
2/9/2024Dynamic Technology Lab Private Ltd27,370$240K0.0%N/A0.031%
2/8/2024Great Lakes Advisors LLC233,958$2.06M0.0%+5.3%0.266%
2/8/2024Fairhaven Wealth Management LLC14,859$131K0.0%N/A0.017%
2/8/2024Essex Investment Management Co. LLC122,419$1.08M0.2%+46.2%0.139%
2/7/2024Principal Financial Group Inc.269,718$2.37M0.0%-72.0%0.307%
2/7/2024BNP Paribas Financial Markets47,886$421K0.0%-66.3%0.055%
2/7/2024Teacher Retirement System of Texas19,357$170K0.0%-18.9%0.022%
2/7/2024Versor Investments LP13,500$119K0.0%N/A0.015%
2/6/2024Charles Schwab Investment Management Inc.677,364$5.95M0.0%+2.1%0.771%
2/6/2024Swiss National Bank164,650$1.45M0.0%-10.9%0.188%
2/5/2024Victory Capital Management Inc.10,554$93K0.0%N/A0.012%
2/5/2024Sargent Investment Group LLC13,822$121K0.0%N/A0.016%
2/1/2024Jennison Associates LLC1,032,352$9.07M0.0%+3.5%1.176%
2/1/2024Handelsbanken Fonder AB20,800$183K0.0%+54.1%0.024%
1/31/2024Federated Hermes Inc.82,177$722K0.0%+111.9%0.094%
1/24/2024China Universal Asset Management Co. Ltd.10,155$89K0.0%+351.3%0.012%
1/17/2024 Assenagon Asset Management S.A.198,846$1.75M0.0%-52.0%0.226%
1/16/2024 Legato Capital Management LLC57,652$507K0.1%+48.8%0.066%
1/12/2024SG Americas Securities LLC62,598$550K0.0%N/A0.071%
1/9/2024 Daymark Wealth Partners LLC29,000$255K0.0%+20.8%0.033%
1/8/2024Harbor Capital Advisors Inc.55,422$487K0.1%+35.2%0.063%
1/4/2024 DNB Asset Management AS34,652$305K0.0%+44.7%0.039%
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>
12/18/2023Vanguard Group Inc.4,791,459$54.96M0.0%+3.0%5.457%
12/13/2023Teachers Retirement System of The State of Kentucky40,431$464K0.0%+47.6%0.046%
12/1/2023Wellington Management Group LLP1,082,420$12.42M0.0%+3.6%1.233%
11/22/2023Polar Capital Holdings Plc4,160,311$47.72M0.3%-0.2%4.738%
11/22/2023Public Sector Pension Investment Board176,000$2.02M0.0%-30.7%0.200%
11/15/2023Rubric Capital Management LP1,600,000$18.35M0.7%N/A1.822%
11/15/2023EULAV Asset Management600,000$6.88M0.3%+275.0%0.683%
11/14/2023Lazard Asset Management LLC77,200$885K0.0%-99.4%0.088%
11/14/2023Schonfeld Strategic Advisors LLC201,634$2.31M0.0%+140.0%0.230%
11/14/2023Rubric Capital Management LP1,600,000$18.35M0.7%N/A1.822%
11/14/2023Nomura Holdings Inc.22,500$258K0.0%N/A0.026%
11/14/2023Bamco Inc. NY1,020,234$11.70M0.0%-9.1%1.162%
11/14/2023Profund Advisors LLC34,961$401K0.0%+87.9%0.040%
11/13/2023Federated Hermes Inc.38,788$445K0.0%+502.0%0.044%
11/13/2023Invesco Ltd.2,902,440$33.29M0.0%+66.0%3.305%
11/13/2023FMR LLC1,894,107$21.73M0.0%-3.2%2.157%
11/13/2023Rafferty Asset Management LLC20,491$235K0.0%+127.3%0.023%
11/13/2023Rhenman & Partners Asset Management AB361,679$4.15M0.4%+194.0%0.412%
11/9/2023Deutsche Bank AG45,042$517K0.0%+13.1%0.051%
11/9/2023Essex Investment Management Co. LLC83,748$961K0.2%-23.1%0.095%
11/9/2023Innovis Asset Management LLC38,501$442K0.2%+266.1%0.044%
11/9/2023Canada Pension Plan Investment Board7,700$88K0.0%N/A0.009%
11/8/2023Campbell & CO Investment Adviser LLC100,907$1.16M0.1%+537.3%0.115%
11/8/2023Charles Schwab Investment Management Inc.663,538$7.61M0.0%+5.8%0.754%
11/8/2023Swiss National Bank184,750$2.12M0.0%+1.2%0.210%
11/7/2023Great Lakes Advisors LLC222,077$2.55M0.0%+13.7%0.252%
11/7/2023Fox Run Management L.L.C.18,360$211K0.1%N/A0.021%
11/7/2023Jump Financial LLC18,122$208K0.0%-86.0%0.021%
11/6/2023 Assenagon Asset Management S.A.414,055$4.75M0.0%N/A0.471%
11/6/2023 Los Angeles Capital Management LLC18,976$218K0.0%+122.5%0.022%
11/2/2023 Rice Hall James & Associates LLC683,937$7.85M0.5%+23.8%0.778%
11/2/2023Principal Financial Group Inc.963,029$11.05M0.0%+55.2%1.095%
11/2/2023RF&L Wealth Management LLC28,000$321K0.3%+40.0%0.032%
10/31/2023Jennison Associates LLC997,616$11.44M0.0%-45.8%1.134%
10/30/2023CIBC Asset Management Inc326,707$3.75M0.0%+40.2%0.371%
10/27/2023 Allspring Global Investments Holdings LLC4,424$51K0.0%-99.6%0.005%
10/27/2023Assetmark Inc.3,257$37K0.0%+63.2%0.004%
10/26/2023Inspire Investing LLC26,592$305K0.0%+113.7%0.030%
10/25/2023Zurcher Kantonalbank Zurich Cantonalbank18,083$207K0.0%+17.0%0.021%
10/23/2023Commonwealth Equity Services LLC99,129$1.14M0.0%+3.6%0.113%
10/20/2023Harbor Capital Advisors Inc.40,999$470K0.1%+29.4%0.047%
10/13/2023 DnB Asset Management AS23,946$275K0.0%+10.0%0.027%
10/10/2023 Daymark Wealth Partners LLC24,000$275K0.0%+71.4%0.027%
9/21/2023Barclays PLC280,758$7.11M0.0%+1.0%0.319%
8/18/2023 Legato Capital Management LLC39,766$1.01M0.1%+18.9%0.045%
8/14/2023NinePointTwo Capital LLC8,444$213K0.1%N/A0.010%
8/14/2023West Tower Group LLC1,548$39K0.0%N/A0.002%
8/14/2023UniSuper Management Pty Ltd317,680$8.04M0.1%N/A0.361%
8/14/2023Driehaus Capital Management LLC201,566$5.10M0.1%N/A0.229%
8/14/2023Thrivent Financial for Lutherans3,247,319$82.19M0.2%+60.7%3.692%
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad)

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>
8/14/2023Granahan Investment Management LLC288,927$7.31M0.2%+18.7%0.328%
8/11/2023Campbell & CO Investment Adviser LLC15,833$401K0.1%N/A0.018%
8/11/2023Capital World Investors9,574,874$242.34M0.0%-5.0%10.885%
8/11/2023Sei Investments Co.271,079$6.86M0.0%-5.3%0.308%
8/11/2023Rhenman & Partners Asset Management AB123,000$3.11M0.3%-46.5%0.140%
8/11/2023JPMorgan Chase & Co.4,693,888$118.80M0.0%-9.1%5.336%
8/11/2023ExodusPoint Capital Management LP27,345$692K0.0%N/A0.031%
8/10/2023MetLife Investment Management LLC43,980$1.11M0.0%+3.9%0.052%
8/10/2023ProShare Advisors LLC16,288$412K0.0%+6.9%0.019%
8/10/2023Profund Advisors LLC18,606$471K0.0%+9.3%0.022%
(Data available from 1/1/2016 forward)

RVNC Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of RVNC shares?

During the previous two years, 169 institutional investors and hedge funds held shares of Revance Therapeutics. The most heavily invested institutionals were JPMorgan Chase & Co. ($118.80M), Capital World Investors ($104.94M), Thrivent Financial for Lutherans ($82.19M), Palo Alto Investors LP ($60.88M), Vanguard Group Inc. ($54.96M), Polar Capital Holdings Plc ($47.72M), and Invesco Ltd. ($33.29M).Learn more on RVNC's institutional investors.

What percentage of Revance Therapeutics stock is owned by institutional investors?

97.70% of Revance Therapeutics stock is owned by institutional investors. Learn more on RVNC's institutional investor holdings.

Which institutional investors have been buying Revance Therapeutics stock?

Of the 146 institutional investors that purchased Revance Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Rubric Capital Management LP ($3.20M), Allspring Global Investments Holdings LLC ($1.54M), Jennison Associates LLC ($1.43M), CIBC Asset Management Inc ($1.42M), Thrivent Financial for Lutherans ($1.30M), Invesco Ltd. ($1.15M), and Two Sigma Investments LP ($1.01M).

How much institutional buying is happening at Revance Therapeutics?

Institutional investors have bought a total of 24,158,189 shares in the last 24 months. This purchase volume represents approximately $481.75M in transactions.

Which Revance Therapeutics major shareholders have been selling company stock?

Of the 68 institutional investors that sold Revance Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Lazard Asset Management LLC ($11.97M), Jennison Associates LLC ($2.60M), Allspring Global Investments Holdings LLC ($1.94M), JPMorgan Chase & Co. ($907.95K), Wellington Management Group LLP ($786.25K), Principal Financial Group Inc. ($693.31K), and Assenagon Asset Management S.A. ($598.41K).

How much institutional selling is happening at Revance Therapeutics?

Institutional investors have sold a total of 24,251,401 shares in the last 24 months. This volume of shares sold represents approximately $376.29M in transactions.


Related Companies:
This page (NASDAQ:RVNC) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
These AI trades triggered this morning (545% return)
Prosper Trading Academy
Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years
Banyan Hill Publishing
He Is Giving Away Bitcoin
Crypto Swap Profits
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Biden out June 13; Kamala won’t replace him?
Paradigm Press
The World's First "$20 Trillion Drug?"
Behind the Markets
Exposed: 10 CENT Crypto to Explode April 20th?
True Market Insiders